Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 137 entries
Sorted by: Best Match Show Resources per page
Monitoring Marine Resources: Ecological and Policy Implications Affecting the Scientific Collecting and Commercial Value of New England Conch (Busycon).

The Biological bulletin

Kaplan IM, Boyer BC.
PMID: 29300647
Biol Bull. 1992 Oct;183(2):379-380. doi: 10.1086/BBLv183n2p379.

No abstract available.

Cite
Kaplan IM, Boyer BC. Monitoring Marine Resources: Ecological and Policy Implications Affecting the Scientific Collecting and Commercial Value of New England Conch (Busycon). Biol Bull. 1992;183(2):379-380doi: 10.1086/BBLv183n2p379.
Kaplan, I. M., & Boyer, B. C. (1992). Monitoring Marine Resources: Ecological and Policy Implications Affecting the Scientific Collecting and Commercial Value of New England Conch (Busycon). The Biological bulletin, 183(2), 379-380. https://doi.org/10.1086/BBLv183n2p379
Kaplan, I M, and Boyer, B C. "Monitoring Marine Resources: Ecological and Policy Implications Affecting the Scientific Collecting and Commercial Value of New England Conch (Busycon)." The Biological bulletin vol. 183,2 (1992): 379-380. doi: https://doi.org/10.1086/BBLv183n2p379
Kaplan IM, Boyer BC. Monitoring Marine Resources: Ecological and Policy Implications Affecting the Scientific Collecting and Commercial Value of New England Conch (Busycon). Biol Bull. 1992 Oct;183(2):379-380. doi: 10.1086/BBLv183n2p379. PMID: 29300647.
Copy Download .nbib Format: NLM
[Homophobia, coping strategies, and sexual identity formation among LGBT youths].

Fractal : revista de psicologia

Goyer MF, Blais M, Hébert M.
PMID: 28191288
Fractal (Niteroi). 2015;27(3):187-194. doi: 10.1590/1984-0292/1489.

Sexual minority youths (SMY) face challenges in consolidating their sexual identity because of heterosexism. The role of homophobic bullying and coping strategies in the formation of sexual identity has been explored within a convenient sample of 262 sexual minority...

Cite
Goyer MF, Blais M, Hébert M. Intimidation homophobe, stratégies d’adaptation et intégration de l’orientation sexuelle. [Homophobia, coping strategies, and sexual identity formation among LGBT youths]. Fractal (Niteroi). 2015;27(3):187-194doi: 10.1590/1984-0292/1489.
Goyer, M. F., Blais, M., & Hébert, M. (2015). Intimidation homophobe, stratégies d’adaptation et intégration de l’orientation sexuelle. [Homophobia, coping strategies, and sexual identity formation among LGBT youths]. Fractal : revista de psicologia, 27(3), 187-194. https://doi.org/10.1590/1984-0292/1489
Goyer, Marie-France, et al. "Intimidation homophobe, stratégies d’adaptation et intégration de l’orientation sexuelle." [Homophobia, coping strategies, and sexual identity formation among LGBT youths]. Fractal : revista de psicologia vol. 27,3 (2015): 187-194. doi: https://doi.org/10.1590/1984-0292/1489
Goyer MF, Blais M, Hébert M. Intimidation homophobe, stratégies d’adaptation et intégration de l’orientation sexuelle. [Homophobia, coping strategies, and sexual identity formation among LGBT youths]. Fractal (Niteroi). 2015;27(3):187-194. doi: 10.1590/1984-0292/1489. French. PMID: 28191288; PMCID: PMC5303011.
Copy Download .nbib Format: NLM
Novel Textile Scaffolds Generated by Flock Technology for Tissue Engineering of Bone and Cartilage.

Materials (Basel, Switzerland)

Walther A, Hoyer B, Springer A, Mrozik B, Hanke T, Cherif C, Pompe W, Gelinsky M.
PMID: 28817062
Materials (Basel). 2012 Mar 22;5(3):540-557. doi: 10.3390/ma5030540.

Textile scaffolds can be found in a variety of application areas in regenerative medicine and tissue engineering. In the present study we used electrostatic flocking-a well-known textile technology-to produce scaffolds for tissue engineering of bone. Flock scaffolds stand out...

Cite
Walther A, Hoyer B, Springer A, et al. Novel Textile Scaffolds Generated by Flock Technology for Tissue Engineering of Bone and Cartilage. Materials (Basel). 2012;5(3):540-557doi: 10.3390/ma5030540.
Walther, A., Hoyer, B., Springer, A., Mrozik, B., Hanke, T., Cherif, C., Pompe, W., & Gelinsky, M. (2012). Novel Textile Scaffolds Generated by Flock Technology for Tissue Engineering of Bone and Cartilage. Materials (Basel, Switzerland), 5(3), 540-557. https://doi.org/10.3390/ma5030540
Walther, Anja, et al. "Novel Textile Scaffolds Generated by Flock Technology for Tissue Engineering of Bone and Cartilage." Materials (Basel, Switzerland) vol. 5,3 (2012): 540-557. doi: https://doi.org/10.3390/ma5030540
Walther A, Hoyer B, Springer A, Mrozik B, Hanke T, Cherif C, Pompe W, Gelinsky M. Novel Textile Scaffolds Generated by Flock Technology for Tissue Engineering of Bone and Cartilage. Materials (Basel). 2012 Mar 22;5(3):540-557. doi: 10.3390/ma5030540. PMID: 28817062; PMCID: PMC5448925.
Copy Download .nbib Format: NLM
Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function.

Clinical and translational science

Fohner AE, Dalton R, Skagen K, Jackson K, Claw KG, Hopkins SE, Robinson R, Khan BA, Prasad B, Schuetz EG, Nickerson DA, Thornton TA, Dillard DA, Boyer BB, Thummel KE, Woodahl EL.
PMID: 33503331
Clin Transl Sci. 2021 Jul;14(4):1292-1302. doi: 10.1111/cts.12970. Epub 2021 Jan 27.

The frequencies of genetic variants in the CYP3A4 and CYP3A5 genes differ greatly across global populations, leading to profound differences in the metabolic activity of these enzymes and resulting drug metabolism rates, with important consequences for therapeutic safety and...

Cite
Fohner AE, Dalton R, Skagen K, et al. Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function. Clin Transl Sci. 2021;14(4):1292-1302doi: 10.1111/cts.12970.
Fohner, A. E., Dalton, R., Skagen, K., Jackson, K., Claw, K. G., Hopkins, S. E., Robinson, R., Khan, B. A., Prasad, B., Schuetz, E. G., Nickerson, D. A., Thornton, T. A., Dillard, D. A., Boyer, B. B., Thummel, K. E., & Woodahl, E. L. (2021). Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function. Clinical and translational science, 14(4), 1292-1302. https://doi.org/10.1111/cts.12970
Fohner, Alison E, et al. "Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function." Clinical and translational science vol. 14,4 (2021): 1292-1302. doi: https://doi.org/10.1111/cts.12970
Fohner AE, Dalton R, Skagen K, Jackson K, Claw KG, Hopkins SE, Robinson R, Khan BA, Prasad B, Schuetz EG, Nickerson DA, Thornton TA, Dillard DA, Boyer BB, Thummel KE, Woodahl EL. Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function. Clin Transl Sci. 2021 Jul;14(4):1292-1302. doi: 10.1111/cts.12970. Epub 2021 Jan 27. PMID: 33503331; PMCID: PMC8301563.
Copy Download .nbib Format: NLM
Measuring advanced theory of mind: Do story-based tasks work?.

Journal of adolescence

Białecka-Pikul M, Szpak M, Zubek J, Stępień-Nycz M, Kołodziejczyk A, Bosacki S, Homer BD.
PMID: 34653852
J Adolesc. 2021 Oct 13;93:28-39. doi: 10.1016/j.adolescence.2021.10.001. Epub 2021 Oct 13.

INTRODUCTION: Although much is known about theory of mind (ToM) development during childhood, data on how these skills develop in adolescence is scarce. This cavity is due in part to the limited knowledge about measures of advanced theory of...

Cite
Białecka-Pikul M, Szpak M, Zubek J, et al. Measuring advanced theory of mind: Do story-based tasks work?. J Adolesc. 2021;93:28-39doi: 10.1016/j.adolescence.2021.10.001.
Białecka-Pikul, M., Szpak, M., Zubek, J., Stępień-Nycz, M., Kołodziejczyk, A., Bosacki, S., & Homer, B. D. (2021). Measuring advanced theory of mind: Do story-based tasks work?. Journal of adolescence, 9328-39. https://doi.org/10.1016/j.adolescence.2021.10.001
Białecka-Pikul, Marta, et al. "Measuring advanced theory of mind: Do story-based tasks work?." Journal of adolescence vol. 93 (2021): 28-39. doi: https://doi.org/10.1016/j.adolescence.2021.10.001
Białecka-Pikul M, Szpak M, Zubek J, Stępień-Nycz M, Kołodziejczyk A, Bosacki S, Homer BD. Measuring advanced theory of mind: Do story-based tasks work?. J Adolesc. 2021 Oct 13;93:28-39. doi: 10.1016/j.adolescence.2021.10.001. Epub 2021 Oct 13. PMID: 34653852.
Copy Download .nbib Format: NLM
The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial.

Arthritis & rheumatology (Hoboken, N.J.)

Winkler A, Sun W, De S, Jiao A, Sharif MN, Symanowicz PT, Athale S, Shin JH, Wang J, Jacobson BA, Ramsey SJ, Dower K, Andreyeva T, Liu H, Hegen M, Homer BL, Brodfuehrer J, Tilley M, Gilbert SA, Danto SI, Beebe JJ, Barnes BJ, Pascual V, Lin LL, Kilty I, Fleming M, Rao VR.
PMID: 34423919
Arthritis Rheumatol. 2021 Dec;73(12):2206-2218. doi: 10.1002/art.41953. Epub 2021 Nov 01.

OBJECTIVE: To investigate the role of PF-06650833, a highly potent and selective small-molecule inhibitor of interleukin-1-associated kinase 4 (IRAK4), in autoimmune pathophysiology in vitro, in vivo, and in the clinical setting.METHODS: Rheumatoid arthritis (RA) inflammatory pathophysiology was modeled in...

Cite
Winkler A, Sun W, De S, et al. The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial. Arthritis Rheumatol. 2021;73(12):2206-2218doi: 10.1002/art.41953.
Winkler, A., Sun, W., De, S., Jiao, A., Sharif, M. N., Symanowicz, P. T., Athale, S., Shin, J. H., Wang, J., Jacobson, B. A., Ramsey, S. J., Dower, K., Andreyeva, T., Liu, H., Hegen, M., Homer, B. L., Brodfuehrer, J., Tilley, M., Gilbert, S. A., Danto, S. I., Beebe, J. J., Barnes, B. J., Pascual, V., Lin, L. L., Kilty, I., Fleming, M., & Rao, V. R. (2021). The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial. Arthritis & rheumatology (Hoboken, N.J.), 73(12), 2206-2218. https://doi.org/10.1002/art.41953
Winkler, Aaron, et al. "The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial." Arthritis & rheumatology (Hoboken, N.J.) vol. 73,12 (2021): 2206-2218. doi: https://doi.org/10.1002/art.41953
Winkler A, Sun W, De S, Jiao A, Sharif MN, Symanowicz PT, Athale S, Shin JH, Wang J, Jacobson BA, Ramsey SJ, Dower K, Andreyeva T, Liu H, Hegen M, Homer BL, Brodfuehrer J, Tilley M, Gilbert SA, Danto SI, Beebe JJ, Barnes BJ, Pascual V, Lin LL, Kilty I, Fleming M, Rao VR. The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial. Arthritis Rheumatol. 2021 Dec;73(12):2206-2218. doi: 10.1002/art.41953. Epub 2021 Nov 01. PMID: 34423919; PMCID: PMC8671219.
Copy Download .nbib Format: NLM
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance.

Annals of the rheumatic diseases

Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Schmajuk G, Tani C, Tedeschi SK, Touma Z, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Costenbader K, Johnson SR.
PMID: 33568386
Ann Rheum Dis. 2021 Feb 10; doi: 10.1136/annrheumdis-2020-219373. Epub 2021 Feb 10.

BACKGROUND/OBJECTIVES: The European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019 classification criteria for systemic lupus erythematosus system showed high specificity, while attaining also high sensitivity. We hereby analysed the performance of the individual criteria items and their...

Cite
Aringer M, Brinks R, Dörner T, et al. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis. 2021;doi: 10.1136/annrheumdis-2020-219373.
Aringer, M., Brinks, R., Dörner, T., Daikh, D., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., Jayne, D., Cervera, R., Costedoat-Chalumeau, N., Diamond, B., Gladman, D. D., Hahn, B., Hiepe, F., Jacobsen, S., Khanna, D., Lerstrøm, K., Massarotti, E., McCune, J., Ruiz-Irastorza, G., Sanchez-Guerrero, J., Schneider, M., Urowitz, M., Bertsias, G., Hoyer, B. F., Leuchten, N., Schmajuk, G., Tani, C., Tedeschi, S. K., Touma, Z., Anic, B., Assan, F., Chan, T. M., Clarke, A. E., Crow, M. K., Czirják, L., Doria, A., Graninger, W., Halda-Kiss, B., Hasni, S., Izmirly, P. M., Jung, M., Kumánovics, G., Mariette, X., Padjen, I., Pego-Reigosa, J. M., Romero-Diaz, J., Rúa-Figueroa, �. �., Seror, R., Stummvoll, G. H., Tanaka, Y., Tektonidou, M. G., Vasconcelos, C., Vital, E. M., Wallace, D. J., Yavuz, S., Meroni, P. L., Fritzler, M. J., Naden, R., Costenbader, K., & Johnson, S. R. (2021). European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Annals of the rheumatic diseases, . https://doi.org/10.1136/annrheumdis-2020-219373
Aringer, Martin, et al. "European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance." Annals of the rheumatic diseases vol. (2021). doi: https://doi.org/10.1136/annrheumdis-2020-219373
Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Schmajuk G, Tani C, Tedeschi SK, Touma Z, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Costenbader K, Johnson SR. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis. 2021 Feb 10; doi: 10.1136/annrheumdis-2020-219373. Epub 2021 Feb 10. PMID: 33568386.
Copy Download .nbib Format: NLM
Scaffold polarity proteins Par3A and Par3B share redundant functions while Par3B acts independent of atypical protein kinase C/Par6 in podocytes to maintain the kidney filtration barrier.

Kidney international

Koehler S, Odenthal J, Ludwig V, Jess DU, Höhne M, Jüngst C, Grawe F, Helmstädter M, Janku JL, Bergmann C, Hoyer PF, Hagmann HHH, Walz G, Bloch W, Niessen C, Schermer B, Wodarz A, Denholm B, Benzing T, Iden S, Brinkkoetter PT.
PMID: 34929254
Kidney Int. 2021 Dec 17; doi: 10.1016/j.kint.2021.11.030. Epub 2021 Dec 17.

Glomerular diseases are a major cause for chronic kidney disorders. In most cases podocyte injury is causative for disease development. Cytoskeletal rearrangements and morphological changes are hallmark features of podocyte injury and result in dedifferentiation and loss of podocytes....

Cite
Koehler S, Odenthal J, Ludwig V, et al. Scaffold polarity proteins Par3A and Par3B share redundant functions while Par3B acts independent of atypical protein kinase C/Par6 in podocytes to maintain the kidney filtration barrier. Kidney Int. 2021;doi: 10.1016/j.kint.2021.11.030.
Koehler, S., Odenthal, J., Ludwig, V., Jess, D. U., Höhne, M., Jüngst, C., Grawe, F., Helmstädter, M., Janku, J. L., Bergmann, C., Hoyer, P. F., Hagmann, H. H. H., Walz, G., Bloch, W., Niessen, C., Schermer, B., Wodarz, A., Denholm, B., Benzing, T., Iden, S., & Brinkkoetter, P. T. (2021). Scaffold polarity proteins Par3A and Par3B share redundant functions while Par3B acts independent of atypical protein kinase C/Par6 in podocytes to maintain the kidney filtration barrier. Kidney international, . https://doi.org/10.1016/j.kint.2021.11.030
Koehler, Sybille, et al. "Scaffold polarity proteins Par3A and Par3B share redundant functions while Par3B acts independent of atypical protein kinase C/Par6 in podocytes to maintain the kidney filtration barrier." Kidney international vol. (2021). doi: https://doi.org/10.1016/j.kint.2021.11.030
Koehler S, Odenthal J, Ludwig V, Jess DU, Höhne M, Jüngst C, Grawe F, Helmstädter M, Janku JL, Bergmann C, Hoyer PF, Hagmann HHH, Walz G, Bloch W, Niessen C, Schermer B, Wodarz A, Denholm B, Benzing T, Iden S, Brinkkoetter PT. Scaffold polarity proteins Par3A and Par3B share redundant functions while Par3B acts independent of atypical protein kinase C/Par6 in podocytes to maintain the kidney filtration barrier. Kidney Int. 2021 Dec 17; doi: 10.1016/j.kint.2021.11.030. Epub 2021 Dec 17. PMID: 34929254.
Copy Download .nbib Format: NLM
SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Disease: A Systematic Literature Review And Meta-Analysis.

Arthritis & rheumatology (Hoboken, N.J.)

Conway R, Grimshaw AA, Konig MF, Putman M, Duarte-García A, Tseng LY, Cabrera DM, Chock YPE, Degirmenci HB, Duff E, Egeli BH, Graef ER, Gupta A, Harkins P, Hoyer BF, Jayatilleke A, Jin S, Kasia C, Khilnani A, Kilian A, Kim AH, Lin CMA, Low C, Proulx L, Sattui SE, Singh N, Sparks JA, Tam H, Ugarte-Gil MF, Ung N, Wang K, Wise LM, Yang Z, Young KJ, Liew JW, Grainger R, Wallace ZS, Hsieh E.
PMID: 34807517
Arthritis Rheumatol. 2021 Nov 22; doi: 10.1002/art.42030. Epub 2021 Nov 22.

OBJECTIVE: The relative risk of SARS-CoV-2 infection and COVID-19 disease severity among people with rheumatic and musculoskeletal diseases (RMD) compared to those without RMD remains uncertain. We sought to quantify the risk for SARS-CoV-2 infection and describe clinical outcomes...

Cite
Conway R, Grimshaw AA, Konig MF, et al. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Disease: A Systematic Literature Review And Meta-Analysis. Arthritis Rheumatol. 2021;doi: 10.1002/art.42030.
Conway, R., Grimshaw, A. A., Konig, M. F., Putman, M., Duarte-García, A., Tseng, L. Y., Cabrera, D. M., Chock, Y. P. E., Degirmenci, H. B., Duff, E., Egeli, B. H., Graef, E. R., Gupta, A., Harkins, P., Hoyer, B. F., Jayatilleke, A., Jin, S., Kasia, C., Khilnani, A., Kilian, A., Kim, A. H., Lin, C. M. A., Low, C., Proulx, L., Sattui, S. E., Singh, N., Sparks, J. A., Tam, H., Ugarte-Gil, M. F., Ung, N., Wang, K., Wise, L. M., Yang, Z., Young, K. J., Liew, J. W., Grainger, R., Wallace, Z. S., Hsieh, E. (2021). SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Disease: A Systematic Literature Review And Meta-Analysis. Arthritis & rheumatology (Hoboken, N.J.), . https://doi.org/10.1002/art.42030
Conway, Richard, et al. "SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Disease: A Systematic Literature Review And Meta-Analysis." Arthritis & rheumatology (Hoboken, N.J.) vol. (2021). doi: https://doi.org/10.1002/art.42030
Conway R, Grimshaw AA, Konig MF, Putman M, Duarte-García A, Tseng LY, Cabrera DM, Chock YPE, Degirmenci HB, Duff E, Egeli BH, Graef ER, Gupta A, Harkins P, Hoyer BF, Jayatilleke A, Jin S, Kasia C, Khilnani A, Kilian A, Kim AH, Lin CMA, Low C, Proulx L, Sattui SE, Singh N, Sparks JA, Tam H, Ugarte-Gil MF, Ung N, Wang K, Wise LM, Yang Z, Young KJ, Liew JW, Grainger R, Wallace ZS, Hsieh E. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Disease: A Systematic Literature Review And Meta-Analysis. Arthritis Rheumatol. 2021 Nov 22; doi: 10.1002/art.42030. Epub 2021 Nov 22. PMID: 34807517.
Copy Download .nbib Format: NLM
Measuring advanced theory of mind: Do story-based tasks work?.

Journal of adolescence

Białecka-Pikul M, Szpak M, Zubek J, Stępień-Nycz M, Kołodziejczyk A, Bosacki S, Homer BD.
PMID: 34653852
J Adolesc. 2021 Dec;93:28-39. doi: 10.1016/j.adolescence.2021.10.001. Epub 2021 Oct 13.

INTRODUCTION: Although much is known about theory of mind (ToM) development during childhood, data on how these skills develop in adolescence is scarce. This cavity is due in part to the limited knowledge about measures of advanced theory of...

Cite
Białecka-Pikul M, Szpak M, Zubek J, et al. Measuring advanced theory of mind: Do story-based tasks work?. J Adolesc. 2021;93:28-39doi: 10.1016/j.adolescence.2021.10.001.
Białecka-Pikul, M., Szpak, M., Zubek, J., Stępień-Nycz, M., Kołodziejczyk, A., Bosacki, S., & Homer, B. D. (2021). Measuring advanced theory of mind: Do story-based tasks work?. Journal of adolescence, 9328-39. https://doi.org/10.1016/j.adolescence.2021.10.001
Białecka-Pikul, Marta, et al. "Measuring advanced theory of mind: Do story-based tasks work?." Journal of adolescence vol. 93 (2021): 28-39. doi: https://doi.org/10.1016/j.adolescence.2021.10.001
Białecka-Pikul M, Szpak M, Zubek J, Stępień-Nycz M, Kołodziejczyk A, Bosacki S, Homer BD. Measuring advanced theory of mind: Do story-based tasks work?. J Adolesc. 2021 Dec;93:28-39. doi: 10.1016/j.adolescence.2021.10.001. Epub 2021 Oct 13. PMID: 34653852.
Copy Download .nbib Format: NLM
Measuring advanced theory of mind: Do story-based tasks work?.

Journal of adolescence

Białecka-Pikul M, Szpak M, Zubek J, Stępień-Nycz M, Kołodziejczyk A, Bosacki S, Homer BD.
PMID: 34653852
J Adolesc. 2021 Dec;93:28-39. doi: 10.1016/j.adolescence.2021.10.001. Epub 2021 Oct 13.

INTRODUCTION: Although much is known about theory of mind (ToM) development during childhood, data on how these skills develop in adolescence is scarce. This cavity is due in part to the limited knowledge about measures of advanced theory of...

Cite
Białecka-Pikul M, Szpak M, Zubek J, et al. Measuring advanced theory of mind: Do story-based tasks work?. J Adolesc. 2021;93:28-39doi: 10.1016/j.adolescence.2021.10.001.
Białecka-Pikul, M., Szpak, M., Zubek, J., Stępień-Nycz, M., Kołodziejczyk, A., Bosacki, S., & Homer, B. D. (2021). Measuring advanced theory of mind: Do story-based tasks work?. Journal of adolescence, 9328-39. https://doi.org/10.1016/j.adolescence.2021.10.001
Białecka-Pikul, Marta, et al. "Measuring advanced theory of mind: Do story-based tasks work?." Journal of adolescence vol. 93 (2021): 28-39. doi: https://doi.org/10.1016/j.adolescence.2021.10.001
Białecka-Pikul M, Szpak M, Zubek J, Stępień-Nycz M, Kołodziejczyk A, Bosacki S, Homer BD. Measuring advanced theory of mind: Do story-based tasks work?. J Adolesc. 2021 Dec;93:28-39. doi: 10.1016/j.adolescence.2021.10.001. Epub 2021 Oct 13. PMID: 34653852.
Copy Download .nbib Format: NLM
The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial.

Arthritis & rheumatology (Hoboken, N.J.)

Winkler A, Sun W, De S, Jiao A, Sharif MN, Symanowicz PT, Athale S, Shin JH, Wang J, Jacobson BA, Ramsey SJ, Dower K, Andreyeva T, Liu H, Hegen M, Homer BL, Brodfuehrer J, Tilley M, Gilbert SA, Danto SI, Beebe JJ, Barnes BJ, Pascual V, Lin LL, Kilty I, Fleming M, Rao VR.
PMID: 34423919
Arthritis Rheumatol. 2021 Dec;73(12):2206-2218. doi: 10.1002/art.41953. Epub 2021 Nov 01.

OBJECTIVE: To investigate the role of PF-06650833, a highly potent and selective small-molecule inhibitor of interleukin-1-associated kinase 4 (IRAK4), in autoimmune pathophysiology in vitro, in vivo, and in the clinical setting.METHODS: Rheumatoid arthritis (RA) inflammatory pathophysiology was modeled in...

Cite
Winkler A, Sun W, De S, et al. The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial. Arthritis Rheumatol. 2021;73(12):2206-2218doi: 10.1002/art.41953.
Winkler, A., Sun, W., De, S., Jiao, A., Sharif, M. N., Symanowicz, P. T., Athale, S., Shin, J. H., Wang, J., Jacobson, B. A., Ramsey, S. J., Dower, K., Andreyeva, T., Liu, H., Hegen, M., Homer, B. L., Brodfuehrer, J., Tilley, M., Gilbert, S. A., Danto, S. I., Beebe, J. J., Barnes, B. J., Pascual, V., Lin, L. L., Kilty, I., Fleming, M., & Rao, V. R. (2021). The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial. Arthritis & rheumatology (Hoboken, N.J.), 73(12), 2206-2218. https://doi.org/10.1002/art.41953
Winkler, Aaron, et al. "The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial." Arthritis & rheumatology (Hoboken, N.J.) vol. 73,12 (2021): 2206-2218. doi: https://doi.org/10.1002/art.41953
Winkler A, Sun W, De S, Jiao A, Sharif MN, Symanowicz PT, Athale S, Shin JH, Wang J, Jacobson BA, Ramsey SJ, Dower K, Andreyeva T, Liu H, Hegen M, Homer BL, Brodfuehrer J, Tilley M, Gilbert SA, Danto SI, Beebe JJ, Barnes BJ, Pascual V, Lin LL, Kilty I, Fleming M, Rao VR. The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial. Arthritis Rheumatol. 2021 Dec;73(12):2206-2218. doi: 10.1002/art.41953. Epub 2021 Nov 01. PMID: 34423919.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 137 entries